Overview

Ferric Carboxymaltose Treatment to Improve Fatigue Symptoms in Iron-deficient Non-anaemic Women of Child Bearing Age

Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
research study of Ferric carboxymaltose to treat fatigue/exhaustion symptoms, believed to be due to iron deficiency.
Phase:
Phase 4
Details
Lead Sponsor:
Vifor Inc.
Vifor Pharma
Collaborator:
SGS S.A.
Treatments:
Ferric Compounds